JPY 1002.0
(-0.2%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 11.42 Billion JPY | -31.82% |
2022 | 16.75 Billion JPY | -14.76% |
2021 | 19.65 Billion JPY | 27.18% |
2020 | 15.45 Billion JPY | 83.49% |
2019 | 8.42 Billion JPY | 21.2% |
2018 | 6.94 Billion JPY | 0.71% |
2017 | 6.89 Billion JPY | -3.66% |
2016 | 7.16 Billion JPY | 10.43% |
2015 | 6.48 Billion JPY | -4.44% |
2014 | 6.78 Billion JPY | 26.21% |
2013 | 5.37 Billion JPY | 3.66% |
2012 | 5.18 Billion JPY | -7.71% |
2011 | 5.61 Billion JPY | 12.97% |
2010 | 4.97 Billion JPY | -15.0% |
2009 | 5.85 Billion JPY | -1.94% |
2008 | 5.96 Billion JPY | -3.45% |
2007 | 6.18 Billion JPY | -10.78% |
2006 | 6.92 Billion JPY | -2.93% |
2005 | 7.13 Billion JPY | 30.09% |
2004 | 5.48 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 10.23 Billion JPY | -10.34% |
2023 Q1 | 12.45 Billion JPY | -25.63% |
2023 FY | 11.42 Billion JPY | -31.82% |
2023 Q3 | 10.56 Billion JPY | -5.33% |
2023 Q4 | 11.42 Billion JPY | 8.14% |
2023 Q2 | 11.15 Billion JPY | -10.45% |
2022 Q4 | 16.75 Billion JPY | 24.7% |
2022 Q2 | 13.07 Billion JPY | 0.09% |
2022 Q1 | 13.06 Billion JPY | -33.51% |
2022 FY | 16.75 Billion JPY | -14.76% |
2022 Q3 | 13.43 Billion JPY | 2.71% |
2021 Q1 | 19.07 Billion JPY | 23.46% |
2021 Q2 | 20.01 Billion JPY | 4.92% |
2021 Q3 | 16.66 Billion JPY | -16.74% |
2021 FY | 19.65 Billion JPY | 27.18% |
2021 Q4 | 19.65 Billion JPY | 17.93% |
2020 Q3 | 13.27 Billion JPY | 31.36% |
2020 Q2 | 10.1 Billion JPY | 26.13% |
2020 FY | 15.45 Billion JPY | 83.49% |
2020 Q1 | 8.01 Billion JPY | -4.81% |
2020 Q4 | 15.45 Billion JPY | 16.35% |
2019 Q4 | 8.42 Billion JPY | 21.19% |
2019 Q3 | 6.94 Billion JPY | 10.64% |
2019 FY | 8.42 Billion JPY | 21.2% |
2019 Q2 | 6.28 Billion JPY | 0.48% |
2019 Q1 | 6.25 Billion JPY | -10.03% |
2018 Q4 | 6.94 Billion JPY | -7.55% |
2018 Q3 | 7.51 Billion JPY | 17.19% |
2018 FY | 6.94 Billion JPY | 0.71% |
2018 Q2 | 6.41 Billion JPY | -4.64% |
2018 Q1 | 6.72 Billion JPY | -2.52% |
2017 Q3 | 6.44 Billion JPY | 2.59% |
2017 Q2 | 6.28 Billion JPY | -11.07% |
2017 Q1 | 7.06 Billion JPY | -1.33% |
2017 FY | 6.89 Billion JPY | -3.66% |
2017 Q4 | 6.89 Billion JPY | 7.01% |
2016 Q2 | 5.57 Billion JPY | -4.29% |
2016 Q3 | 6.26 Billion JPY | 12.38% |
2016 FY | 7.16 Billion JPY | 10.43% |
2016 Q1 | 5.82 Billion JPY | -10.16% |
2016 Q4 | 7.16 Billion JPY | 14.29% |
2015 Q3 | 6.21 Billion JPY | 2.46% |
2015 Q1 | 5.51 Billion JPY | -18.72% |
2015 FY | 6.48 Billion JPY | -4.44% |
2015 Q2 | 6.06 Billion JPY | 10.03% |
2015 Q4 | 6.48 Billion JPY | 4.29% |
2014 Q3 | 5.91 Billion JPY | -14.11% |
2014 Q2 | 6.88 Billion JPY | 21.18% |
2014 Q1 | 5.68 Billion JPY | 5.65% |
2014 Q4 | 6.78 Billion JPY | 14.77% |
2014 FY | 6.78 Billion JPY | 26.21% |
2013 FY | 5.37 Billion JPY | 3.66% |
2013 Q2 | 10.04 Billion JPY | 109.05% |
2013 Q1 | 4.8 Billion JPY | -7.37% |
2013 Q4 | 5.37 Billion JPY | 9.51% |
2013 Q3 | 4.9 Billion JPY | -51.12% |
2012 Q3 | 4.79 Billion JPY | 1.98% |
2012 Q1 | 5.01 Billion JPY | -10.77% |
2012 Q2 | 4.69 Billion JPY | -6.3% |
2012 Q4 | 5.18 Billion JPY | 8.24% |
2012 FY | 5.18 Billion JPY | -7.71% |
2011 Q3 | 4.81 Billion JPY | 2.62% |
2011 Q4 | 5.61 Billion JPY | 16.65% |
2011 Q1 | 4.49 Billion JPY | -9.71% |
2011 FY | 5.61 Billion JPY | 12.97% |
2011 Q2 | 4.69 Billion JPY | 4.52% |
2010 Q2 | 4.92 Billion JPY | 5.83% |
2010 Q4 | 4.97 Billion JPY | 7.87% |
2010 Q3 | 4.61 Billion JPY | -6.28% |
2010 Q1 | 4.64 Billion JPY | -20.56% |
2010 FY | 4.97 Billion JPY | -15.0% |
2009 Q3 | 4.92 Billion JPY | 0.12% |
2009 FY | 5.85 Billion JPY | -1.94% |
2009 Q4 | 5.85 Billion JPY | 18.73% |
2009 Q2 | 4.92 Billion JPY | 0.0% |
2008 Q4 | 5.96 Billion JPY | 0.0% |
2008 FY | 5.96 Billion JPY | -3.45% |
2007 FY | 6.18 Billion JPY | -10.78% |
2006 FY | 6.92 Billion JPY | -2.93% |
2005 FY | 7.13 Billion JPY | 30.09% |
2004 FY | 5.48 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
KOHJIN BIO CO LTD | 3.24 Billion JPY | -251.717% |
PRISM BioLab Co.,LTD | 63.41 Million JPY | -17909.494% |
GNI Group Ltd. | 26.34 Billion JPY | 56.647% |
Linical Co., Ltd. | 10.3 Billion JPY | -10.821% |
Trans Genic Inc. | 3.81 Billion JPY | -199.538% |
MEDINET Co., Ltd. | 590.2 Million JPY | -1834.924% |
Soiken Holdings Inc. | 697.02 Million JPY | -1538.396% |
Cytori Cell Research Institute, Inc. | 3.02 Billion JPY | -278.052% |
AnGes, Inc. | 2.78 Billion JPY | -309.412% |
OncoTherapy Science, Inc. | 513.6 Million JPY | -2123.49% |
Nxera Pharma Co., Ltd. | 90.38 Billion JPY | 87.366% |
Immuno-Biological Laboratories Co., Ltd. | 353.27 Million JPY | -3132.646% |
NanoCarrier Co., Ltd. | 1.64 Billion JPY | -592.167% |
Carna Biosciences, Inc. | 472.35 Million JPY | -2317.673% |
CanBas Co., Ltd. | 91.98 Million JPY | -12314.663% |
D. Western Therapeutics Institute, Inc. | 1.09 Billion JPY | -944.252% |
RaQualia Pharma Inc. | 809.83 Million JPY | -1310.173% |
Chiome Bioscience Inc. | 593.73 Million JPY | -1823.43% |
Kidswell Bio Corporation | 4.25 Billion JPY | -168.448% |
PeptiDream Inc. | 29.11 Billion JPY | 60.775% |
Oncolys BioPharma Inc. | 566.5 Million JPY | -1915.887% |
Ribomic Inc. | 155.8 Million JPY | -7229.487% |
SanBio Company Limited | 2.25 Billion JPY | -406.454% |
Healios K.K. | 11.28 Billion JPY | -1.187% |
BrightPath Biotherapeutics Co., Ltd. | 251.26 Million JPY | -4444.93% |
Kubota Pharmaceutical Holdings Co., Ltd. | 369 Million JPY | -2994.851% |
Delta-Fly Pharma, Inc. | 241.49 Million JPY | -4628.837% |
StemRIM | 187 Million JPY | -6006.952% |
CellSource Co., Ltd. | 677.73 Million JPY | -1585.014% |
FunPep Company Limited | 189.32 Million JPY | -5931.987% |
Kringle Pharma, Inc. | 596.95 Million JPY | -1813.042% |
Stella Pharma Corporation | 1.44 Billion JPY | -691.072% |
TMS Co., Ltd. | 97.68 Million JPY | -11590.16% |
Noile-Immune Biotech Inc. | 91.49 Million JPY | -12381.693% |
Cuorips Inc. | 200.96 Million JPY | -5582.695% |
K Pharma,Inc. | 209.13 Million JPY | -5360.614% |
ReproCELL Incorporated | 741.03 Million JPY | -1441.094% |
PhoenixBio Co., Ltd. | 917.71 Million JPY | -1144.398% |
StemCell Institute Inc. | 3.85 Billion JPY | -196.588% |
Japan Tissue Engineering Co., Ltd. | 908.43 Million JPY | -1157.113% |
CellSeed Inc. | 301.04 Million JPY | -3693.428% |